Jones Robert Clyde
No ORCID on file
· 86 papers in corpus
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…
1985
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treati…